You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The study, called TRAMmoniTTR, will longitudinally monitor the clinical status of both symptomatic and asymptomatic participants with variants in the TTR gene.
In Science this week: gene expression signature linked to nonalcoholic fatty liver disease progression, and more.
Metagenomic sequencing and fecal metabolite profiling uncovered major depressive disorder-related gut microbe changes and a combinatorial marker set.
In Cell this week: SARS-CoV-2 evolution and spread in North Carolina, protein and other features that distinguish mild and severe COVID-19, and more.
In PLOS this week: gene expression in muscle stem cells, blood metabolomic study of diabetic retinopathy complications, and more.
A quasi-paired cohort analysis identified shifts in the detoxifying function of gut microbes from individuals with autism spectrum disorder.
The researchers also developed a web-based tool based on the data they gathered that could help predict COVID-19 severity in patients.
The firm said it would use the funding to grow its client base and further R&D programs using machine learning for biomarker discovery and precision medicine.
Using transcriptomic, metabolomic, metagenomic, and other data types, a team identified purine metabolism as a potential target for intervention.
Metabolon's Precision Metabolomics platform identifies pharmacodynamic, efficacy, and response biomarkers and tracks changes in biological pathways.
Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.
23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.
The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.
In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.